PGD Department, Sydney IVF, NSW 2000, Australia.
Mol Hum Reprod. 2010 May;16(5):329-37. doi: 10.1093/molehr/gaq013. Epub 2010 Feb 19.
Preimplantation genetic diagnosis (PGD) for structural chromosome abnormalities traditionally uses fluorescence in situ hybridization (FISH) techniques. Although relatively straight forward, FISH is technically demanding with several process problems which include cell loss, cell overlap, variable cell fixation and hybridization as well as sample mosaicism. Increasingly, alternative techniques for chromosome analysis in embryos are being investigated in an attempt to improve on current test outcomes. Here, we report on the first routine application of a polymerase chain reaction (PCR)-based protocol for translocation analysis utilizing multiplexed short tandem repeat (STR) markers located on both segments of the translocated chromosomes. Resulting STR profiles permit the analysis of qualitative dosage of each chromosomal segment to identify translocation malsegregants from the balanced/normal chromosome complements. A total of 29 patients have undergone clinical PGD testing of 78 embryos using this method. The proportion of alternate segregations (i.e. balanced carrier and non-carriers) detected for reciprocal and Robertsonian translocation carriers was 33% and 77%, respectively. Fetal heart pregnancy rates per embryo transferred was 46% for reciprocal carriers and 40% for Robertsonian carriers (mean number of embryos transferred was 1.0). This novel approach can be applied easily within any existing PGD PCR laboratory and allows for a significant improvement in the identification of segregation types when compared with the standard FISH protocol using combinations of distal and proximal probes. This approach increases test robustness and reliability with improved interpretation of segregation outcomes, decreased analysis time and also enables the straight forward combining of structural chromosome analysis with monogenic testing.
胚胎植入前遗传学诊断(PGD)传统上使用荧光原位杂交(FISH)技术来诊断结构性染色体异常。尽管 FISH 技术相对简单,但它在技术上要求很高,存在多个过程问题,包括细胞丢失、细胞重叠、细胞固定和杂交的变异性以及样本镶嵌性。为了改善当前的测试结果,越来越多的胚胎染色体分析替代技术正在被研究。在这里,我们报告了第一个常规应用聚合酶链反应(PCR)为基础的方案,利用位于易位染色体两端的多重短串联重复(STR)标记来分析易位。所得 STR 谱允许分析每个染色体片段的定性剂量,以鉴定易位重排体与平衡/正常染色体成分。共有 29 名患者接受了 78 个胚胎的临床 PGD 检测,使用该方法。对于相互易位和罗伯逊易位携带者,检测到的替代分离(即平衡携带者和非携带者)的比例分别为 33%和 77%。对于相互易位携带者,每个胚胎转移的胎儿心脏妊娠率为 46%,对于罗伯逊易位携带者为 40%(平均转移胚胎数为 1.0)。与使用远端和近端探针组合的标准 FISH 方案相比,这种新方法可以在任何现有的 PGD PCR 实验室中轻松应用,并且可以显著提高分离类型的识别能力。这种方法提高了测试的稳健性和可靠性,改善了对分离结果的解释,减少了分析时间,并且可以轻松地将结构染色体分析与单基因测试相结合。